Every material Form 8-K Mettler Toledo filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Mettler-Toledo reported third-quarter 2025 sales up 8% to $1,029.7 million and diluted EPS of $10.57, compared with $9.96 a year earlier. The company raised its full-year 2025 adjusted EPS forecast to $42.05 to $42.25 from $42.20 at the top end of the prior range of $41.70 to $42.20, and authorized an additional $2.75 billion for share repurchases.
Q3 2025 adjusted EPS was $11.15, up 9% from $10.21; GAAP diluted EPS was $10.57 versus $9.96.
Full-year 2025 local currency sales growth is forecast at approximately 2%, and adjusted EPS at $42.05 to $42.25 versus prior guidance of $41.70 to $42.20.
The Board added $2.75 billion to the share repurchase program, which had $1.1 billion remaining as of September 30, 2025.
For the fourth quarter, adjusted EPS is forecast at $12.68 to $12.88, which includes an estimated 7% gross headwind from higher tariff costs.
Mettler-Toledo amended the employment agreement of executive Marc de La Guéronnière on October 21, 2025. The amendment sets 2026 as a transition year ahead of his potential retirement at the end of 2026, with him working at half his prior full-time commitment. The change affects compensation and no equity grants for 2026, which is relevant to shareholders as it reflects how the company is planning the executive's departure.
Amendment dated October 21, 2025 to employment agreement from January 27, 2011
Executive to work at 50% of prior full-time commitment in 2026, with potential retirement at end of 2026
Base salary set at EUR 140,000 for 2026, plus an additional EUR 150,000 bonus tied to successful transition, payable January 2027
No additional equity compensation grants in 2026; existing grants continue to vest
Mettler-Toledo's board appointed Pablo Perversi, President of Europe at Danone, as an independent director effective November 6, 2025, and increased the board from eight to nine directors. The board has not yet decided his committee assignments, and the company announced the appointment in an August 4, 2025 press release. The filing covers board composition only and includes no financial results or guidance.
Board appointed Pablo Perversi on July 31, 2025; his directorship takes effect November 6, 2025
Board size rises from eight to nine directors, effective November 6, 2025
Perversi was previously Chief Innovation, Quality, and Sustainability Officer at Barry Callebaut and held roles at Unilever from 1993 to 2017
Board has not yet determined Perversi's committee assignments
Mettler-Toledo reported second-quarter 2025 reported sales of $983.2 million, up 4% from a year earlier, and adjusted EPS of $10.09, up 5%. GAAP diluted EPS fell to $9.76 from $10.37, which included a one-time non-cash tax benefit in the prior-year period. The company raised its full-year 2025 adjusted EPS forecast to $42.10 to $42.60 from $41.25 to $42.00, while local currency sales growth guidance of 1% to 2% was unchanged.
Q2 2025 reported sales rose 4% to $983.2 million; local currency sales rose 2%.
Q2 diluted EPS was $9.76 vs. $10.37 a year earlier, which included a $1.07 per share one-time tax benefit; adjusted EPS was $10.09 vs. $9.65.
Full-year 2025 adjusted EPS forecast raised to $42.10 to $42.60, from $41.25 to $42.00.
Estimated gross incremental tariff costs were cut to approximately $60 million annualized from $115 million, due to lower tariff rates.
Mettler-Toledo's compensation committee approved 2025 long-term incentive awards for its named executive officers, with half granted on May 8, 2025 and half scheduled for November 2025. The filing says the CEO's target LTI value for the May grant rose about 5% versus 2024 and the other named executives' rose about 10%, which affects shareholders mainly through executive pay costs and dilution from the equity awards.
Awards split into 1/3 performance share units, 1/3 non-qualified stock options and 1/3 restricted stock units, with half granted May 8, 2025 and half in November 2025.
CEO Patrick Kaltenbach's target LTI value increased by approximately 5% versus 2024 under the May grant.
Named executive officers' target LTI value increased by approximately 10% versus 2024 under the May grant.
CEO received 679 PSUs, 1,855 options and 728 RSUs in the May grant; CFO Shawn P. Vadala received 235 PSUs, 640 options and 252 RSUs.
Mettler-Toledo reported first-quarter 2025 sales of $883.7 million, down 5% from the prior year, and adjusted EPS of $8.19, down 8%. The company cut its full-year 2025 adjusted EPS forecast to $41.25 to $42.00 from $42.35 to $43.00, citing higher tariff costs and shipping delays from 2023 that shifted sales.
Q1 2025 reported sales were $883.7 million, down 5%; local currency sales fell 3%, or rose 3% excluding delayed shipments from the prior year.
Q1 2025 GAAP diluted EPS was $7.81 versus $8.24; adjusted EPS was $8.19 versus $8.89.
Full-year 2025 local currency sales growth guidance is 1% to 2%, versus prior guidance of about 3%.
Management estimates gross incremental global tariff costs of about $115 million on an annualized basis, with mitigating actions expected to fully offset them next year.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Mettler Toledo filing is on SEC EDGAR ↗. 8-K briefs of other companies →